Connect with us
European Gaming Congress 2024

Fintech PR

A report from People’s Daily: PLA support base in Djibouti pursues peace, cooperation, friendship




Beijing, Sept. 12, 2023 /PRNewswire/ — A ceremony marking the entry of troops into the Chinese People’s Liberation Army (PLA) support base in Djibouti was held at the base’s barracks on August 1, 2017, marking the completion and official operation of the base.

The establishment of the PLA Djibouti base was a decision made by the two countries after friendly negotiations.

In accordance with UN Security Council resolutions, China has deployed vessels to the Gulf of Aden and the waters off the Somali coast on escort missions since 2008. During the process, Chinese officers and men encountered difficulties in replenishing food and fuel, and Djibouti offered logistical support in multiple instances.

The construction of the support base enables China to better fulfill its international obligations such as escorts and humanitarian rescue in the Gulf of Aden and the waters off the Somali coast. It also contributes to the economic and social development of Djibouti and enables China to make new and greater contributions to safeguarding peace and stability in Africa and the world.

Over the past six years, the capabilities of the support base have steadily improved. The base has provided efficient and professional support for escort fleets and Chinese peacekeeping troops deployed to South Sudan, Mali and the Democratic Republic of the Congo. The construction and growth of the support base has strongly aided the Chinese military’s escort missions in the Gulf of Aden and peacekeeping operations in Africa, while making prominent contributions to regional peace and stability and safeguarding international maritime channels.


The Chinese support base plays an important role in maintaining regional trade flows, Aboubaker Omar Hadi, chairman of the Djibouti Ports and Free Zones Authority, told People’s Daily.

The PLA support base promotes mutual trust and understanding, and conveys a message of peace and friendship.

Since its establishment, the base has held over 10 joint exercises and drills with Djiboutian and other foreign troops in Djibouti. It has also participated in more than 200 bilateral and multilateral exchange activities, and held five multinational basketball and football tournaments. This has continuously advanced bilateral and multilateral exchanges and showcased the open and confident image of the Chinese military.

Since 2019, the PLA Support Base Hospital in Djibouti has partnered with the general hospital of Djibouti’s military for paired assistance. So far, China has sent over 100 medical experts to Djibouti, assisted with 45 surgeries there and held a series of bilateral clinical skills training sessions.

The base has become an important platform for medical exchanges, said Feng Dan, a medic who has joined multiple exchange activities. “We are very proud to be doctors at the base,” Feng told People’s Daily.


Fran, a military doctor at the Djibouti Military Hospital of the Djiboutian Republican Guard, said that China’s long-term medical assistance is important for Djibouti and it is hoped that there will be further exchanges with the Chinese side to improve local medical capabilities.

Li Zhaohui, head of the PLA support base, noted that the base hopes to strengthen its communication with Djibouti and foreign troops in Djibouti, constantly enhance practical cooperation with them, fulfill China’s international obligations, and work together with them to cope with security threats and challenges, so as to make greater contributions to regional peace and stability.

Teenagers are the future of Djibouti’s economic and social development, as well as the hope for the continuous friendship between China and Djibouti. In order to improve the teaching conditions in local schools, the support base has established a regular education assistance mechanism with Djibouti, which conducts public welfare assistance activities.

In January this year, the support base donated computers, projectors, desks and chairs, sports equipment and stationery to three primary schools in the Balbala district of Djibouti City. It was the support base’s third round of public welfare assistance to local schools.

“The new desks, chairs, and equipment have made our school more beautiful,” said Hassan, a student at the PK12 Primary School in Djibouti City, carrying his new blue backpack with a happy smile on his face.


Minister of National Education and Vocational Training of Djibouti Moustapha Mohamed Mahamoud said that with the help of the PLA support base, the teaching environment of local schools has been improved, providing children with better conditions for growth.

“I’m grateful to Chinese doctors and nurses,” said Mohamed Ali Ahmed, a 66-year-old man from Djibouti, who had his cataract cured at the PLA support base after having had the problem for six years.

In December 2019, the support base kicked off a 25-day medical campaign in cooperation with Djibouti’s Ministry of Health, which offered free cataract surgery for over 100 local patients including Ahmed. The campaign received widespread praise from the local community.

Ten medical staff members of the support base were awarded with the Independence Day Medal signed by President Ismail Omar Guelleh of Djibouti.

Saleh Banoita Tourab, then secretary-general of the Ministry of Health in Djibouti, noted that the Chinese military doctors have brought great relief to local cataract patients, and their act of compassion will be forever remembered by the people of Djibouti.


In 2019, Djibouti experienced a rare heavy rainfall, which caused flooding and resulted in casualties. In response to Djibouti’s request, the PLA support base dispatched troops to provide assistance to the affected population, and thousands of people received timely help.

Idle, a resident of Djibouti, and his family and friends were severely affected by the flood. “The house of a friend of mine was almost swallowed by the flood, and we felt desperate,” he said. Fortunately, Chinese soldiers arrived and helped them with drainage and dredging. “We are grateful to the Chinese military,” Idle said.

Since its establishment, the support base has been committed to assisting in the local economic and social development of Djibouti through various initiatives such as public welfare education, medical services, and disaster relief. These practical actions have earned widespread praise from the government and people of Djibouti.

“When I first arrived in Djibouti in 2018, there were few locals who could speak Chinese,” said Zhang Daqian, a PLA officer who has been stationed at the base for five years. He told People’s Daily that whenever the soldiers go out on missions nowadays, local people would warmly greet them in Chinese and give thumbs-up to them.

“This change is a testament to the unwavering dedication of Chinese soldiers who have been serving the local community. It inspires us and motivates us to continue our efforts,” Zhang said.



View original content:–pla-support-base-in-djibouti-pursues-peace-cooperation-friendship-301924970.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting


The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision


The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895


EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”


Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.


BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading

Latest news